BVX — Bivictrix Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Bivictrix Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.862	6.06	3.29	3.28	0.957
Net Total Accounts Receivable
Net Total Receivables	0.143	0.26	0.565	0.454	0.456
Prepaid Expenses
Total Current Assets	1	6.54	3.96	3.82	1.48
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.063	0.339	0.571	0.476	0.366
Total Assets	1.07	6.88	4.54	4.29	1.84
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.33	0.379	0.391	0.624	0.415
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	1	0.554	0.579	0.758	0.494
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	0.067	6.33	3.96	3.54	1.35
Total Liabilities & Shareholders' Equity	1.07	6.88	4.54	4.29	1.84
Total Common Shares Outstanding